Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.
Ann Oncol. 2024 Jan;35(1):66-76. doi: 10.1016/j.annonc.2023.10.004. Epub 2023 Oct 20.
Ann Oncol. 2024.
PMID: 37866811
Clinical Trial.
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer.
Shaw AT, Bauer TM, de Marinis F, Felip E, Goto Y, Liu G, Mazieres J, Kim DW, Mok T, Polli A, Thurm H, Calella AM, Peltz G, Solomon BJ; CROWN Trial Investigators.
Shaw AT, et al.
N Engl J Med. 2020 Nov 19;383(21):2018-2029. doi: 10.1056/NEJMoa2027187.
N Engl J Med. 2020.
PMID: 33207094
Clinical Trial.
Item in Clipboard
Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study.
Duruisseaux M, Besse B, Cadranel J, Pérol M, Mennecier B, Bigay-Game L, Descourt R, Dansin E, Audigier-Valette C, Moreau L, Hureaux J, Veillon R, Otto J, Madroszyk-Flandin A, Cortot A, Guichard F, Boudou-Rouquette P, Langlais A, Missy P, Morin F, Moro-Sibilot D.
Duruisseaux M, et al. Among authors: madroszyk flandin a.
Oncotarget. 2017 Mar 28;8(13):21903-21917. doi: 10.18632/oncotarget.15746.
Oncotarget. 2017.
PMID: 28423535
Free PMC article.
Item in Clipboard
Lung cancer in elderly patients: a retrospective analysis of practice in a single institution.
Madroszyk-Flandin A, Bagattini S, Gonçalves A, Salem N, Viret F, Viallat JR, Rousseau F, Protière C, Bertucci F, Maraninchi D, Viens P.
Madroszyk-Flandin A, et al.
Crit Rev Oncol Hematol. 2007 Oct;64(1):43-8. doi: 10.1016/j.critrevonc.2007.06.009.
Crit Rev Oncol Hematol. 2007.
PMID: 17826629
Item in Clipboard
Randomized Phase II Trial Evaluating Treatment with EGFR-TKI Associated with Antiestrogen in Women with Nonsquamous Advanced-Stage NSCLC: IFCT-1003 LADIE Trial.
Mazieres J, Barlesi F, Rouquette I, Molinier O, Besse B, Monnet I, Audigier-Valette C, Toffart AC, Renault PA, Fraboulet S, Hiret S, Mennecier B, Debieuvre D, Westeel V, Masson P, Madroszyk-Flandin A, Pichon E, Cortot AB, Amour E, Morin F, Zalcman G, Moro-Sibilot D, Souquet PJ.
Mazieres J, et al. Among authors: madroszyk flandin a.
Clin Cancer Res. 2020 Jul 1;26(13):3172-3181. doi: 10.1158/1078-0432.CCR-19-3056. Epub 2020 Mar 6.
Clin Cancer Res. 2020.
PMID: 32144133
Clinical Trial.
Item in Clipboard
From randomised clinical trials to clinical practice : a pragmatic cost-effectiveness analysis of Paclitaxel in first-line therapy for advanced ovarian cancer.
Limat S, Woronoff-Lemsi MC, Menat C, Madroszyk-Flandin A, Merrouche Y.
Limat S, et al. Among authors: madroszyk flandin a.
Pharmacoeconomics. 2004;22(10):633-41. doi: 10.2165/00019053-200422100-00002.
Pharmacoeconomics. 2004.
PMID: 15244489
Item in Clipboard
Cite
Cite